Figures & data
Figure 1 Effects of 12 weeks’ treatment on sleep latency, night-time awakenings, and total sleep time.
Abbreviation: BL, baseline.
![Figure 1 Effects of 12 weeks’ treatment on sleep latency, night-time awakenings, and total sleep time.](/cms/asset/7505cc50-889b-4893-ba6e-8839bb39f93f/dndt_a_116476_f0001_b.jpg)
Figure 2 Change from BL in PDSS item scores after 12 weeks of treatment with levodopa or levodopa + rasagiline.
Abbreviations: BL, baseline; PDSS, Parkinson’s Disease Sleep Scale.
![Figure 2 Change from BL in PDSS item scores after 12 weeks of treatment with levodopa or levodopa + rasagiline.](/cms/asset/61177689-5d9f-40ec-becb-6b0f1c963488/dndt_a_116476_f0002_b.jpg)
Table S1 Baseline characteristics and demographics